Birmingham Hematology and Oncology — Birmingham, Alabama

Birmingham Hematology and Oncology is a clinical research site located in Birmingham, Alabama, United States 35205.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Birmingham Hematology and Oncology has participated in 13 clinical trials with 1 currently active.

Therapeutic areas: Lymphoma, T-Cell, Peripheral, Prostate Cancer, Gastric Cancer Adenocarcinoma Metastatic.

Sponsors: Eisai Inc., Agennix, US Oncology Research.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Birmingham Hematology and Oncology?

Birmingham Hematology and Oncology has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Birmingham Hematology and Oncology conducted?

Birmingham Hematology and Oncology has 13 clinical trials on record, with 1 currently active. Their work covers Lymphoma, T-Cell, Peripheral, Prostate Cancer, Gastric Cancer Adenocarcinoma Metastatic.

Is Birmingham Hematology and Oncology accredited by Crixeo Health?

Yes — Birmingham Hematology and Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Birmingham Hematology and Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.